Monday, August 4, 2025

Latest

Cronos Group, Ginkgo Bioworks Achieve Partnership Productivity Target For CBG Acid

Cronos Group, Inc. (TSX: CRON) and Ginkgo Bioworks announced this morning that its partnership has achieved the productivity target for cannabigerolic acid (CBGA). The milestone is part of the two companies’ set of productivity targets in aiming to produce eight cultured cannabinoids.

This achievement sets the ground for Cronos Group’s planned cannabigerol product launch this fall. The cannabis firm was able to take advantage Ginkgo Bioworks’ platform for organism design and development to achieve commercial-scale production for the cannabinoid.

“Ginkgo’s platform enables companies across a multitude of industries to reach their customers with better products. We are proud to use our combined capabilities to make the benefits of cannabinoids more accessible to consumers,” said Cronos Group President and CEO Kurt Schmidt.

The partnership between the two companies was launched in 2018 with the goal of accessing rare molecules in the cannabis plant to develop eight molecules. Cronos Group provides its expertise on cannabis biological structure while Ginkgo Bioworks brings to the table its knowledge on designing microorganisms for the production of cultured products.

With the achievement of the final productivity target for CBGA, Cronos Group is expected to issue a milestone payment of approximately 1.5 million common shares.

Earlier this month, the cannabinoid company posted -101% gross margin for Q2 2021, leading Canaccord Genuity to lower its 12-month price target for the company down to $7.00. Meanwhile, Ginkgo Bioworks announced in May 2021 its reverse merger deal with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG).

Cronos Group last traded at $7.90 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization unless otherwise mentioned. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

San Dimas: First Majestic Silver’s Sleeper Asset

New Gold Q2 Earnings: Record Free Cash Flow

STLLR Gold: The Tower Gold PEA

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

PI Financial, Canaccord Revise Cronos Group Estimates Downward Following Q3 Results

Last week, Cronos Group (TSX: CRON) (NASDAQ: CRON) reported its third quarter 2020 results. The...

Sunday, November 8, 2020, 11:39:00 AM

Cronos Group Doesn’t Expect To File Delayed Financials Until The End Of January 2022

It appears that money is no substitute for ability. Cronos Group (TSX: CRON) on Friday...

Monday, December 20, 2021, 09:17:51 AM

Cronos Group Subject Of SEC Inquiry

This evening, MarketWatch reporter Max Cherney broke the story that Cronos Group (TSX: CRON) (NASDAQ:...

Thursday, March 19, 2020, 09:59:02 PM

Cronos Group Sees Adler, Gorenstein Sell Multiple Millions Worth Of Shares

November has been a busy month for Cronos Group (TSX: CRON) (NASDAQ: CRON) in terms...

Thursday, November 19, 2020, 05:36:05 PM

Cronos Group Exits Its US Operations After Spending $300 Million To Acquire Them During Height Of Cannabis Bubble

Cronos Group (NASDAQ: CRON) announced on Wednesday that it will be closing down its existing US...

Thursday, June 1, 2023, 08:37:40 AM